...
首页> 外文期刊>Nucleic Acid Therapeutics >MicroRNAs Enable mRNA Therapeutics to Selectively Program Cancer Cells to Self-Destruct
【24h】

MicroRNAs Enable mRNA Therapeutics to Selectively Program Cancer Cells to Self-Destruct

机译:microRNA使mRNA治疗剂能够选择性地将癌细胞进行自我毁灭

获取原文
获取原文并翻译 | 示例
           

摘要

The advent of therapeutic mRNAs significantly increases the possibilities of protein-based biologics beyond those that can be synthesized by recombinant technologies (eg, monoclonal antibodies, extracellular enzymes, and cytokines). In addition to their application in the areas of vaccine development, immune-oncology, and protein replacement therapies, one exciting possibility is to use therapeutic mRNAs to program undesired, diseased cells to synthesize a toxic intracellular protein, causing cells to self-destruct. For this approach to work, however, methods are needed to limit toxic protein expression to the intended cell type. Here, we show that inclusion of microRNA target sites in therapeutic mRNAs encoding apoptotic proteins, Caspase or PUMA, can prevent their expression in healthy hepatocytes while triggering apoptosis in hepatocellular carcinoma cells.
机译:治疗性MRNA的出现显着提高了基于蛋白质的生物学的可能性,超出了可通过重组技术(例如单克隆抗体,细胞外酶和细胞因子)合成的那些。 除了在疫苗开发的应用外,免疫肿瘤学和蛋白质替代疗法外,一种令人兴奋的可能性是使用治疗方法来编程不希望的患病细胞来合成有毒细胞内蛋白,导致细胞自毁。 然而,对于这种工作方法,需要将有毒蛋白质表达限制为预期细胞类型。 在这里,我们表明,在编码凋亡蛋白,胱天蛋白酶或露壳的治疗性mRNA中将microRNA靶位点包含在健康肝细胞中,同时引发肝细胞癌细胞的细胞凋亡。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号